Evidence map›Paper›PMID 33103737›Full record

ArticleBrain : a journal of neurology2020

YIF1B mutations cause a post-natal neurodevelopmental syndrome associated with Golgi and primary cilium alterations.

Jorge Diaz, Xavier Gérard, Michel-Boris Emerit, Julie Areias, David Geny, Julie Dégardin, Manuel Simonutti, Marie-Justine Guerquin, Thibault Collin, Cécile Viollet and 25 more

Erratum issuedOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Brain : a journal of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Intraflagellar Transport Proteins as Regulators of Primary Cilia Length.Frontiers in cell and developmental biology · 2021
    Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

35 authors at 12 institutions in 5 countries.

Jorge DiazINSERM UMR894, Center for Psychiatry and Neuroscience, Paris F-75014, Université Paris Descartes, Sorbonne Paris Cité - Paris 5, France.
Xavier GérardINSERM UMR-S1163 Imagine Institute for Genetic Diseases, Paris Descartes-Sorbonne Paris Cité University, France.
Michel-Boris EmeritINSERM UMR894, Center for Psychiatry and Neuroscience, Paris F-75014, Université Paris Descartes, Sorbonne Paris Cité - Paris 5, France.
Julie AreiasINSERM UMR894, Center for Psychiatry and Neuroscience, Paris F-75014, Université Paris Descartes, Sorbonne Paris Cité - Paris 5, France.
David GenyINSERM UMR894, Center for Psychiatry and Neuroscience, Paris F-75014, Université Paris Descartes, Sorbonne Paris Cité - Paris 5, France.
Julie DégardinINSERM UMR-S968, Institut de la vision, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris F-75012, Université Pierre et Marie Curie, France.
Manuel SimonuttiINSERM UMR-S968, Institut de la vision, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris F-75012, Université Pierre et Marie Curie, France.
Marie-Justine GuerquinCEA, DSV, IRCM, SCSR, Fontenay-Aux-Roses, France.
Thibault CollinSaint Pères Paris Institute for the Neurosciences CNRS - UMR 8003 Université de Paris, Paris 75006, France.
Cécile ViolletINSERM UMR894, Center for Psychiatry and Neuroscience, Paris F-75014, Université Paris Descartes, Sorbonne Paris Cité - Paris 5, France.
Jean-Marie BillardINSERM UMR894, Center for Psychiatry and Neuroscience, Paris F-75014, Université Paris Descartes, Sorbonne Paris Cité - Paris 5, France.
Christine MétinINSERM, UMR-S1270, Institut du Fer à Moulin, Sorbonne Université, Paris F-75005, France.
Laurence HubertINSERM UMR-S1163 Imagine Institute for Genetic Diseases, Paris Descartes-Sorbonne Paris Cité University, France.
Farzaneh LartiUniversity of Social Welfare and Rehabilitation Sciences, Genetics Research Center, Tehran 19834, Iran.
Kimia KahriziUniversity of Social Welfare and Rehabilitation Sciences, Genetics Research Center, Tehran 19834, Iran.
Rebekah JoblingThe Hospital for Sick Children, Molecular Genetics, Toronto, Canada.
Emanuele AgoliniLaboratory of Medical Genetics, Bambino Gesù Children's Hospital, 00146 Rome, Italy.
Ranad ShaheenKing Faisal Specialist Hospital and Research Center, Developmental Genetics Unit, Riyadh 11211, Saudi Arabia.
Alban ZiglerCHU Angers, Génétique, France.
Virginie Rouiller-FabreCEA, DSV, IRCM, SCSR, Fontenay-Aux-Roses, France.
Jean-Michel RozetINSERM UMR-S1163 Imagine Institute for Genetic Diseases, Paris Descartes-Sorbonne Paris Cité University, France.
Serge PicaudINSERM UMR-S968, Institut de la vision, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris F-75012, Université Pierre et Marie Curie, France.
Antonio NovelliLaboratory of Medical Genetics, Bambino Gesù Children's Hospital, 00146 Rome, Italy.
Seham AlameerDepartment of Pediatrics, King Khaled National Guard Hospital, King Abdulaziz Medical City, Jeddah, Saudi Arabia.
Hossein NajmabadiUniversity of Social Welfare and Rehabilitation Sciences, Genetics Research Center, Tehran 19834, Iran.
Ronald CohnThe Hospital for Sick Children, Molecular Genetics, Toronto, Canada.
Arnold MunnichINSERM UMR-S1163 Imagine Institute for Genetic Diseases, Paris Descartes-Sorbonne Paris Cité University, France.
Magalie BarthCHU Angers, Génétique, France.
Licia LugliDivision of Neonatal Intensive Care Unit, Department of Pediatrics, University Hospital, 41125 Modena, Italy.
Fowzan S AlkurayaKing Faisal Specialist Hospital and Research Center, Developmental Genetics Unit, Riyadh 11211, Saudi Arabia.
Susan BlaserDivision of Neuroradiology, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
Maha GashlanKing Faisal Specialist Hospital and Research Center, Developmental Genetics Unit, Riyadh 11211, Saudi Arabia.
Claude BesmondINSERM UMR-S1163 Imagine Institute for Genetic Diseases, Paris Descartes-Sorbonne Paris Cité University, France.
Michèle DarmonINSERM UMR894, Center for Psychiatry and Neuroscience, Paris F-75014, Université Paris Descartes, Sorbonne Paris Cité - Paris 5, France.
Justine MassonINSERM UMR894, Center for Psychiatry and Neuroscience, Paris F-75014, Université Paris Descartes, Sorbonne Paris Cité - Paris 5, France.
Délégation Paris 5 · FRInstitut de la Vision · FRKing Faisal Specialist Hospital & Research Centre · SAUniversity of Social Welfare and Rehabilitation Sciences · IRBambino Gesù Children's Hospital · ITCentre Hospitalier Universitaire d'Angers · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRHospital for Sick Children · CACentre National de la Recherche Scientifique · FRInserm · FRKing Abdulaziz Medical City · SAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human post-natal neurodevelopmental delay is often associated with cerebral alterations that can lead, by themselves or associated with peripheral deficits, to premature death. Here, we report the clinical features of 10 patients from six independent families with mutations in the autosomal YIF1B gene encoding a ubiquitous protein involved in anterograde traffic from the endoplasmic reticulum to the cell membrane, and in Golgi apparatus morphology. The patients displayed global developmental delay, motor delay, visual deficits with brain MRI evidence of ventricle enlargement, myelination alterations and cerebellar atrophy. A similar profile was observed in the Yif1b knockout (KO) mouse model developed to identify the cellular alterations involved in the clinical defects. In the CNS, mice lacking Yif1b displayed neuronal reduction, altered myelination of the motor cortex, cerebellar atrophy, enlargement of the ventricles, and subcellular alterations of endoplasmic reticulum and Golgi apparatus compartments. Remarkably, although YIF1B was not detected in primary cilia, biallelic YIF1B mutations caused primary cilia abnormalities in skin fibroblasts from both patients and Yif1b-KO mice, and in ciliary architectural components in the Yif1b-KO brain. Consequently, our findings identify YIF1B as an essential gene in early post-natal development in human, and provide a new genetic target that should be tested in patients developing a neurodevelopmental delay during the first year of life. Thus, our work is the first description of a functional deficit linking Golgipathies and ciliopathies, diseases so far associated exclusively to mutations in genes coding for proteins expressed within the primary cilium or related ultrastructures. We therefore propose that these pathologies should be considered as belonging to a larger class of neurodevelopmental diseases depending on proteins involved in the trafficking of proteins towards specific cell membrane compartments.

Indexed as

AnimalsCells, CulturedCiliaFemaleGolgi ApparatusHumansMaleMiceMice, KnockoutMutationNeurodevelopmental DisordersVesicular Transport ProteinsVesicular Transport ProteinsYIF1A protein, humanERGolgineurodevelopmental delayprimary cilium

Identifiers

PMID33103737
OpenAlexW3094424837

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.